[
    [
        {
            "time": "",
            "original_text": "诚意药业（603811）2020年年报及2021年一季报点评：业绩略超我们预期，海洋生物医药龙头前景广阔！【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "诚意药业",
                    "2020年年报",
                    "2021年一季报",
                    "业绩略超预期",
                    "海洋生物医药",
                    "龙头",
                    "东吴医药",
                    "朱国广团队"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "海洋生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "诚意药业（603811）2020年年报及2021年一季报点评：业绩略超我们预期，海洋生物医药龙头前景广阔！【东吴医药朱国广团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]